Lakefront Biotherapeutics (LKFT) Revenue (2014 - 2026)
Lakefront Biotherapeutics' (LKFT) quarterly Revenue came in at $7.6 million in Q1 2026, down 90.38% year-on-year from $78.9 million in Q1 2025, and down 99.28% on a QoQ basis from $1.0 billion in Q4 2025.
Lakefront Biotherapeutics (LKFT) Revenue (2014 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has 13 years of Revenue data on file, last reported at $7.6 million in Q1 2026.
- On a quarterly basis, Revenue fell 90.38% year-over-year to $7.6 million in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 398.27% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 339.54% from the prior year.
- Revenue for Q1 2026 stood at $7.6 million, down from $1.0 billion in the prior quarter.
- Over the last five years, Revenue for LKFT reached as high as $1.0 billion in Q4 2025 and fell as low as -$55.1 million in Q2 2024.
- Historically, Revenue has averaged $122.9 million across 5 years, with a median of $66.6 million in 2023.
- Across the five-year window, Revenue plunged 184.3% in 2024 and soared 8432.91% in 2025, its largest moves.
- Year by year, Revenue stood at $184.4 million in 2022, then plunged by 34.48% to $120.8 million in 2023, then sank by 89.83% to $12.3 million in 2024, then surged by 8432.91% to $1.0 billion in 2025, then tumbled by 99.28% to $7.6 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $7.6 million in Q1 2026, $1.0 billion in Q4 2025, and $83.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 1.83 Bn | -1.66 Bn | 1.97 Mn | 7.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.59 Mn |
| Dec 31, 2025 | 1.05 Bn |
| Sep 30, 2025 | 83.15 Mn |
| Jun 30, 2025 | 73.94 Mn |
| Mar 31, 2025 | 78.87 Mn |
| Dec 31, 2024 | 12.29 Mn |
| Sep 30, 2024 | 207.44 Mn |
| Jun 30, 2024 | -55.10 Mn |
| Mar 31, 2024 | 67.82 Mn |
| Dec 31, 2023 | 120.83 Mn |
| Sep 30, 2023 | 66.60 Mn |
| Jun 30, 2023 | 65.36 Mn |
| Mar 31, 2023 | 62.87 Mn |
| Dec 31, 2022 | 184.42 Mn |
| Sep 30, 2022 | 25.30 Mn |
| Jun 30, 2022 | 22.40 Mn |
| Mar 31, 2022 | 16.17 Mn |
| Dec 31, 2021 | 261.15 Mn |
| Sep 30, 2021 | 374.90 Mn |
| Jun 30, 2021 | 168.32 Mn |